World CB & CDx Summit Japan

Meet the ARC Team at World CDx Japan

19–20 May 2026 | Japan

Will you be attending World CDx Japan this May?

The ARC team will be there from Tuesday 19 May to Wednesday 20 May 2026, meeting with partners and industry colleagues to discuss how ARC’s Regulatory, Pharma Tech and Laboratory services can support diagnostic, clinical trial and companion diagnostic programmes.

Why meet with ARC?

ARC Laboratory has received formal confirmation from the UK MHRA that, due to our Northern Ireland location, we can self-designate to enable testing of both EU and UK clinical trial samples under the IVDR Health Institution Exemption, Article 5(5).

This means eligible studies can avoid the need for a separate IVDR Performance Study application or Competent Authority approval.

What this means for your studies

• Faster study start-up
• Reduced regulatory burden
• Greater flexibility as assays evolve across EU and UK programmes

The ARC team will also be speaking during the trip, with details to be confirmed soon.

If you’re attending, feel free to book a short meeting with us to discuss how ARC could support your test, trial or study.

Catch up with us at World CDx Japan

Meet the Expert: David Ribeiro, Laboratory Director – ARC Research Laboratories

• Extensive experience across large & small pharma
• 10 years leading an IVD company in clinical research

Meet David to discuss your study